openPR Logo
Press release

Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent and Collaborations

Japanese Encephalitis Therapeutics - Pipeline Analysis,

Japanese encephalitis is a viral infection that spreads by mosquito bites. The study analyzed that the Japanese encephalitis therapeutics pipeline comprises approximately 12 drug candidates in different stages of development.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/japanese-encephalitis-therapeutics-pipeline/report-sample

The companies developing drugs for the treatment of Japanese encephalitis are laying more emphasis on the drug candidates to be developed as vaccines, due to the promising results shown by these candidates the in the clinical development. Based on molecule type, around 75.0% of the therapeutic candidates are being developed as vaccines, around 13.0% are made as peptide and 12.0% are being developed as small molecule.

In September 2017, VABIOTECH in collaboration with National Institute of Hygiene and Epidemiology (NIHE), Vietnam, initiated a Phase III, randomized, multi-centered, parallel groups assignment trial to assess the immunogenicity and safety of the JECEVAX in healthy male as well as female children of age between nine to 24 months.

Browse report at: https://www.psmarketresearch.com/market-analysis/japanese-encephalitis-therapeutics-pipeline

Some of the key players developing drugs for the treatment of Japanese encephalitis include Shandong Hengye Biotech, Co. Ltd., Panacea Biotec Ltd., and Ennaid Therapeutics, LLC.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent and Collaborations here

News-ID: 1264002 • Views:

More Releases from P&S Intelligence - Pharmaceuticals

Cyclin-Dependent Kinase Inhibitors Therapeutics Key Players Analysis - Merck, Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim
Cyclin-Dependent Kinase Inhibitors Therapeutics Key Players Analysis - Merck, El …
The study analyzed that the CDK inhibitors therapeutics pipeline comprises approximately 24 drug candidates in different stages of development. CDKs are the catalytic subunits of serine or threonine protein kinases that regulate the checkpoints in the cell cycle to control the proliferative capacity of cancerous cells. These proteins form cyclin-CDK complex which gets activated after phosphorylation, leading to cell proliferation. Download report sample at: http://bit.ly/2eqiPu5 **Various collaborations for CDK inhibitors drug development Eli Lilly
Systemic Lupus Erythematosus Pipeline Analysis - Anthera Pharmaceuticals, Inc., Genentech, Inc., Merck KGaA
Systemic Lupus Erythematosus Pipeline Analysis - Anthera Pharmaceuticals, Inc., …
The study analyzed that the systemic lupus erythematosus pipeline comprises of 57 drug candidates in different stages of development. Explore report sample at: https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis/report-sample Systemic lupus erythematosus is a type of lupus in which the immune system damages its own tissues. The disease affects many parts of the body including skin, joints, lungs, brain, blood vessels and kidneys. The systemic lupus erythematosus is caused by impaired immune system due to which the
Herpes Simplex Virus Infections Therapeutic - Pipeline Analysis, Clinical Trials and Developments
Herpes Simplex Virus Infections Therapeutic - Pipeline Analysis, Clinical Trials …
The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development. As per the findings of the research, most of the drug candidates are being developed to be administered by oral route. Explore report sample at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to,
mTOR Inhibitors Therapeutics Pipeline - Analysis, Clinical Trials, Collaborations and Developments
mTOR Inhibitors Therapeutics Pipeline - Analysis, Clinical Trials, Collaboration …
According to the research findings, most of the drug candidates that act as mTOR inhibitors are being developed as small molecules, further supported by the fact that small molecules have several advantages such as it can be manufactured with production rate higher than any other molecule types. Explore report sample at: https://www.psmarketresearch.com/market-analysis/mtor-inhibitors-therapeutics/report-sample The positive clinical results of mTOR inhibitors drug candidates is a key factor driving the pipeline growth. For instance, F.

All 5 Releases


More Releases for Japanese

Top-grossing Japanese Mobile Game, “Logres: Japanese RPG” launches Beta Test …
Tokyo, Japan – April 6, 2017 – Marvelous Inc. and Aiming Inc. launches the Beta test of the English version of its top-grossing MMORPG title in Japan, Logres: Japanese RPG. An epic online multiplayer game featuring anime-style graphics and downloaded by millions after its launch in Japan, the Beta test of the English version will be open to Android users in United States, Canada, Australia, United Kingdom, and New Zealand
English version of top grossing Japanese Mobile Game, “Logres: Japanese RPG” …
Tokyo, Japan – March 27, 2017 – Marvelous Inc. and Aiming Inc. announces the beta test schedule for the English version of its top-grossing MMORPG title, Logres: Japanese RPG, in selected countries. An anime-style MMORPG boasting over 8 million downloads in Japan, the English version of this epic online multiplayer JRPG is now ready to make its mark in the global mobile market. The CBT will be open to United
Why the Japanese live long?
Japan is one of the most fast aging societies on the planet. A quarter of the populace is age 65 or more. Around 3.1 million residents will be 65 or more in Tokyo itself, by 2025, as per the ministry of health. Keeping those individuals productive and healthy is secret to controlling expenses for national health care system of Japan and helping balance a falling birth rate. The Japanese survive longer
10-03-2011 | Health & Medicine
FEBICO
Japanese secret to longevity
It is slowly reaching the season of autumn, where temperature difference between night and day is clearly noticeable. This may cause vasoconstriction which may lead to cardiovascular diseases. According to a British research, cardiovascular diseases have a 25% higher percentage of occurring in autumn than in any other seasons. Low temperature may cause instability in the blood vessels, high blood pressure, poor blood circulation and other physiological changes. Coupled with
Sonicbeetle - Annakim [japanese summer bass]
Sonicbeetle is a newcomer on the scene with a fresh take on dance music his first release on Inductive [Annakim] cranks up the summer heat with a wide eyed tropical meets stellar sound orgy tweaked to keep the nite club waves crashing and dancin. A dangerous combo of derbouka drums laced in a bouncy beat feed with boisterous 808 kicks tractored with youyous synth sounds and togorian echoes. More info :
Cutting Off Japanese ODA
To make recovery for economy and infrastructure, Japan has to decrease official development assistance (ODA) for other countries. Due to the effect of earthquake and tsunami, Japan has faced with serious problem of both material and human. Although the country has received aid from all over the world, Japan needs more to recover injury by the disaster. On April 22nd , the Japanese government passed the first supplementary budget about 4,000